Literature DB >> 21985268

Antenatal closure of the ductus arteriosus and hydrops fetalis.

Josephine Wyatt-Ashmead1.   

Abstract

Antenatal closure of the ductus arteriosus has been speculated, but rarely reported, as a cause of hydrops fetalis. The purpose of this prospective autopsy study was to find the incidence of antenatal closure of the ductus arteriosus and hydrops fetalis in a high-risk obstetric population and to find associated factors that might give clues to the cause of antenatal closure of the ductus arteriosus. Antenatal closure of the ductus arteriosus had to be stringently sought by in situ examination. Fifteen stillborns with antenatal closure of the ductus arteriosus were found in 684 perinatal autopsies (2.2%), including 511 stillborns (2.9%). All 15 stillborns with antenatal closure of the ductus arteriosus also had hydrops fetalis and accounted for 35% of the 43 stillborns with hydrops fetalis. Antenatal closure of the ductus arteriosus in these 15 stillborns was not associated with maternal aspirin use but was associated with a myriad of factors, including intrauterine infection (60%), umbilical cord abnormalities (67%), and retroplacental hemorrhage (87%), that can cause hypoxic-ischemic stress.

Entities:  

Mesh:

Year:  2011        PMID: 21985268     DOI: 10.2350/07-11-0368.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  4 in total

Review 1.  Aspirin Use in Women: Current Perspectives and Future Directions.

Authors:  Amy Sarma; Nandita S Scott
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

2.  Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).

Authors:  Neil O'Gorman; David Wright; Daniel L Rolnik; Kypros H Nicolaides; Liona C Poon
Journal:  BMJ Open       Date:  2016-06-28       Impact factor: 2.692

Review 3.  Aspirin for Prevention of Preeclampsia.

Authors:  A Atallah; E Lecarpentier; F Goffinet; M Doret-Dion; P Gaucherand; V Tsatsaris
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

4.  Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort.

Authors:  Katarina Dathe; Johanna Frank; Stephanie Padberg; Stefanie Hultzsch; Evelin Beck; Christof Schaefer
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-26       Impact factor: 3.105

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.